Paul J Kim1, Morteza Mahmoudi1, Xiaohu Ge1, Yuka Matsuura1, Ildiko Toma1, Scott Metzler1, Nigel G Kooreman1, John Ramunas1, Colin Holbrook1, Michael V McConnell1, Helen Blau1, Phillip Harnish1, Eric Rulifson1, Phillip C Yang2. 1. From the Division of Cardiovascular Medicine, Department of Medicine, Stanford University Medical Center, CA (P.J.K., M.M., X.G., Y.M., I.T., S.M., N.G.K., M.V.M., E.R., P.C.Y.); Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, CA (J.R., C.H., H.B.); and Eagle Vision Pharmaceutical Corporation, Exton, PA (P.H.). 2. From the Division of Cardiovascular Medicine, Department of Medicine, Stanford University Medical Center, CA (P.J.K., M.M., X.G., Y.M., I.T., S.M., N.G.K., M.V.M., E.R., P.C.Y.); Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, CA (J.R., C.H., H.B.); and Eagle Vision Pharmaceutical Corporation, Exton, PA (P.H.). phillip@stanford.edu.
Abstract
RATIONALE: The mechanism of functional restoration by stem cell therapy remains poorly understood. Novel manganese-enhanced MRI and bioluminescence reporter gene imaging were applied to follow myocardial viability and cell engraftment, respectively. Human-placenta-derived amniotic mesenchymal stem cells (AMCs) demonstrate unique immunoregulatory and precardiac properties. In this study, the restorative effects of 3 AMC-derived subpopulations were examined in a murine myocardial injury model: (1) unselected AMCs, (2) ckit(+)AMCs, and (3) AMC-derived induced pluripotent stem cells (MiPSCs). OBJECTIVE: To determine the differential restorative effects of the AMC-derived subpopulations in the murine myocardial injury model using multimodality imaging. METHODS AND RESULTS: SCID (severe combined immunodeficiency) mice underwent left anterior descending artery ligation and were divided into 4 treatment arms: (1) normal saline control (n=14), (2) unselected AMCs (n=10), (3) ckit(+)AMCs (n=13), and (4) MiPSCs (n=11). Cardiac MRI assessed myocardial viability and left ventricular function, whereas bioluminescence imaging assessed stem cell engraftment during a 4-week period. Immunohistological labeling and reverse transcriptase polymerase chain reaction of the explanted myocardium were performed. The unselected AMC and ckit(+)AMC-treated mice demonstrated transient left ventricular functional improvement. However, the MiPSCs exhibited a significantly greater increase in left ventricular function compared with all the other groups during the entire 4-week period. Left ventricular functional improvement correlated with increased myocardial viability and sustained stem cell engraftment. The MiPSC-treated animals lacked any evidence of de novo cardiac differentiation. CONCLUSION: The functional restoration seen in MiPSCs was characterized by increased myocardial viability and sustained engraftment without de novo cardiac differentiation, indicating salvage of the injured myocardium.
RATIONALE: The mechanism of functional restoration by stem cell therapy remains poorly understood. Novel manganese-enhanced MRI and bioluminescence reporter gene imaging were applied to follow myocardial viability and cell engraftment, respectively. Human-placenta-derived amniotic mesenchymal stem cells (AMCs) demonstrate unique immunoregulatory and precardiac properties. In this study, the restorative effects of 3 AMC-derived subpopulations were examined in a murinemyocardial injury model: (1) unselected AMCs, (2) ckit(+)AMCs, and (3) AMC-derived induced pluripotent stem cells (MiPSCs). OBJECTIVE: To determine the differential restorative effects of the AMC-derived subpopulations in the murinemyocardial injury model using multimodality imaging. METHODS AND RESULTS:SCID (severe combined immunodeficiency) mice underwent left anterior descending artery ligation and were divided into 4 treatment arms: (1) normal saline control (n=14), (2) unselected AMCs (n=10), (3) ckit(+)AMCs (n=13), and (4) MiPSCs (n=11). Cardiac MRI assessed myocardial viability and left ventricular function, whereas bioluminescence imaging assessed stem cell engraftment during a 4-week period. Immunohistological labeling and reverse transcriptase polymerase chain reaction of the explanted myocardium were performed. The unselected AMC and ckit(+)AMC-treated mice demonstrated transient left ventricular functional improvement. However, the MiPSCs exhibited a significantly greater increase in left ventricular function compared with all the other groups during the entire 4-week period. Left ventricular functional improvement correlated with increased myocardial viability and sustained stem cell engraftment. The MiPSC-treated animals lacked any evidence of de novo cardiac differentiation. CONCLUSION: The functional restoration seen in MiPSCs was characterized by increased myocardial viability and sustained engraftment without de novo cardiac differentiation, indicating salvage of the injured myocardium.
Authors: Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim Journal: Stem Cell Res Date: 2010-01-04 Impact factor: 2.020
Authors: Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp Journal: Circ Res Date: 2012-07-20 Impact factor: 17.367
Authors: Rajesh Dash; Jaehoon Chung; Fumiaki Ikeno; Annett Hahn-Windgassen; Yuka Matsuura; Mihoko V Bennett; Jennifer K Lyons; Tomohiko Teramoto; Robert C Robbins; Michael V McConnell; Alan C Yeung; Todd J Brinton; Phillip P Harnish; Phillip C Yang Journal: Circ Cardiovasc Imaging Date: 2011-06-30 Impact factor: 7.792
Authors: Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa Journal: Lancet Date: 2011-11-14 Impact factor: 79.321
Authors: Takayasu Arai; Theo Kofidis; Jeff W M Bulte; Jorg de Bruin; Ross D Venook; Gerald J Berry; Michael V Mcconnell; Thomas Quertermous; Robert C Robbins; Phillip C Yang Journal: Magn Reson Med Date: 2006-01 Impact factor: 4.668
Authors: Steven T Suhr; Eun Ah Chang; Ramon M Rodriguez; Kai Wang; Pablo J Ross; Zeki Beyhan; Shashanka Murthy; Jose B Cibelli Journal: PLoS One Date: 2009-12-02 Impact factor: 3.240
Authors: Christina L Brunnquell; Reinier Hernandez; Stephen A Graves; Ivy Smit-Oistad; Robert J Nickles; Weibo Cai; M Elizabeth Meyerand; Masatoshi Suzuki Journal: Contrast Media Mol Imaging Date: 2016-07-11 Impact factor: 3.161
Authors: Ji-Hye Jung; Gentaro Ikeda; Yuko Tada; Daniel von Bornstädt; Michelle R Santoso; Christine Wahlquist; Siyeon Rhee; Young-Jun Jeon; Anthony C Yu; Connor G O'brien; Kristy Red-Horse; Eric A Appel; Mark Mercola; Joseph Woo; Phillip C Yang Journal: Basic Res Cardiol Date: 2021-03-19 Impact factor: 17.165
Authors: Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi Journal: Chem Rev Date: 2019-09-06 Impact factor: 60.622